Biotech Firm Claims Some Credit for Groundbreaking Virus Research
New York Times

Radical Numerics turned heads with its announcement about a novel treatment. Now a former partner, Tabula Bioscience, says it performed much of the research.
Summary from New York Times
Read the full story on New York TimesFollow














